CX 2018 Presentations
Please note: Some presentations may not be available as permission may not have been given.
PERIPHERAL PROXIMAL ARTERIAL ISCHAEMIA CONTROVERSIES - Tuesday, 24th April
Venue: Upper Main Auditorium
Time: 08:00 - 18:00
WHETHER to intervene, WHEN to INTERVENE, INTERVENTION METHOD AND FOLLOW-UP
Medical management, diagnosis and decision-making
| Chairing: | Frank Veith, New York, United States |
| Moderator: | Cliff Shearman, Southampton, United Kingdom |
Time: 08:00 - 08:05
Contemporary medical therapy of patients with intermittent claudication and critical limb ischaemia
| Speaker: | Martin Björck, Uppsala, Sweden |
Time: 08:05 - 08:10
What ABPI and toe pressure tells us about the prognosis and how clopidogrel and statins impact it
| Speaker: | Maarit Venermo, Helsinki, Finland |
Time: 08:15 - 08:30
Audience participation and discussion
Severe aortic bifurcation and iliac occlusive arterial disease
Time: 08:30 - 08:35
Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB)
| Speaker: | Kim Taeymans, Edegem, Belgium |
Time: 08:35 - 08:40
Endovascular vs. open treatment of severe aortoiliac occlusive disease-outcomes of kissing self-expanding covered stent for reconstruction of the aortic bifurcation
| Speaker: | Sandro Lepidi, Padua, Italy |
Time: 08:40 - 08:45
Two-year outcomes of complex iliac arterial disease with a balloon-expandable stent trial
| Speaker: | Michael Dake, Stanford, United States |
Endo first vs. open surgery-the evidence
| Chairing: | Roger Greenhalgh, London, United Kingdom |
| Moderator: | Robert Hinchliffe, Bristol, United Kingdom |
Time: 09:00 - 09:10
CX Debate: Common femoral and profunda femoris artery disease are best managed by open surgery
For the motion
Time: 09:00 - 09:05
| Cliff Shearman, Southampton, United Kingdom | |
| CLICK HERE TO VIEW VIDEO |
Against the motion
Time: 09:05 - 09:10
| Yann Goueffic, Nantes, France | |
| CLICK HERE TO VIEW VIDEO |
Time: 09:20 - 09:50
CX Great Debate: Endovascular first for critical limb ischaemia is a concept without evidence
For the motion
Time: 09:20 - 09:25
| Andrew Bradbury, Birmingham, United Kingdom | |
| CLICK HERE TO VIEW VIDEO |
Time: 09:25 - 09:30
| Matthew Menard, Boston, United States | |
| CLICK HERE TO VIEW VIDEO |
Time: 09:30 - 09:35
| Clement Darling III, President, SVS, Albany,, United States | |
| CLICK HERE TO VIEW VIDEO |
Against the motion
Time: 09:35 - 09:40
| Thomas Zeller, Bad Krozingen, Germany | |
| CLICK HERE TO VIEW VIDEO |
Time: 09:40 - 09:45
| Andrew Holden, Auckland, New Zealand | |
| CLICK HERE TO VIEW VIDEO |
Time: 09:45 - 09:50
| Peter Schneider, Honolulu, United States | |
| CLICK HERE TO VIEW VIDEO |
Coffee
Time: 10:00 - 10:30
10:03-10:27 Sponsored Satellite
Intermittent claudication and superficial femoral artery
| Chairing: | Andrew Holden, Auckland, New Zealand |
| Moderator: | Barry Katzen, Miami, United States |
Time: 10:30 - 10:37
Endovascular vs. open surgery of superficial femoral artery disease-ZILVERPASS trial
| Speaker: | Marc Bosiers, Dendermonde, Belgium |
Time: 10:37 - 10:44
Reconstruction of the superficial femoral artery by a dual component flexible stent
| Speaker: | Fabien Thaveau, Strasbourg, France |
Time: 10:44 - 10:51
SUPER B trial
| Speaker: | Michel Reijnen, Arnhem, Netherlands |
Emerging devices and interventional techniques
Vessel preparation devices
Time: 11:01 - 11:11
CX Debate: Directional atherectomy pre-treatment and use of constrained expansion using a sequential dilatation balloon
For the motion
Time: 11:01 - 11:06
| Thomas Zeller, Bad Krozingen, Germany | |
| CLICK HERE TO VIEW VIDEO |
Against the motion
Time: 11:06 - 11:11
| Frans Moll, Utrecht, Netherlands | |
| CLICK HERE TO VIEW VIDEO |
Time: 11:21 - 11:28
The place of atherectomy and DCB
| Speaker: | Michael Lichtenberg, Arnsberg, Germany |
Time: 11:28 - 11:35
The value of debulking first in peripheral arterial disease
| Speaker: | Joerg Tessarek, Lingen, Germany |
Time: 11:35 - 11:42
Treating the superficial femoral artery with a serration balloon catheter
| Speaker: | Peter Schneider, Honolulu, United States |
Late-breaking trials and first-on-podium presentations
| Chairing: | Thomas Zeller, Bad Krozingen, Germany |
| Moderator: | Andrew Holden, Auckland, New Zealand |
Time: 11:52 - 12:02
BATTLE: Randomised controlled trial at one year-paclitaxel-eluting stent vs. bare metal stent
| Speaker: | Yann Goueffic, Nantes, France |
Time: 12:11 - 12:21
BIOLUX P-III
| Speaker: | Gunnar Tepe, Bad Rosenheim, Germany |
Lunch
Time: 12:30 - 13:30
12:30-13:00 Lunch Symposium
Emerging treatment strategies for complex SFA disease
| Chairing: | Thomas Zeller, Bad Krozingen, Germany |
Time: 12:33 - 12:40
IN.PACT Global-severe SFA lesions
| Speaker: | Michel Reijnen, Arnhem, Netherlands |
Time: 12:40 - 12:47
IN.PACT Global-stented vs. non-stented outcomes at two years
| Speaker: | Thomas Zeller, Bad Krozingen, Germany |
Time: 12:47 - 12:54
Patterns of restenosis: What are the data telling us?
| Speaker: | Brian DeRubertis, Los Angeles, United States |
Drug-coated balloons
| Chairing: | Giovanni Torsello, Münster, Germany |
| Moderator: | Frans Moll, Utrecht, Netherlands |
Time: 13:30 - 13:36
DCB vs. PTA-four-year data from IN.PACT SFA trial
| Speaker: | Peter Schneider, Honolulu, United States |
Time: 13:36 - 13:42
Two-year outcomes of AcoArt 1 SFA DCB trial in China
| Speaker: | Wei Guo, Beijing, China |
Time: 13:42 - 13:48
Lutonix long lesion study-24-month outcomes
| Speaker: | Martin Banyai, Luzern, Switzerland |
Time: 13:48 - 13:54
DCB vs. PTA in non-stented lesions-two-year data from IN.PACT SFA Japan trial
| Speaker: | Osamu Iida, Hyogo, Japan |
Time: 14:10 - 14:16
DES vs. DCB-DRASTICO trial
| Speaker: | Francesco Liistro, AREZZO, Italy |
Time: 14:16 - 14:22
Podium 1st: Effectiveness of paclitaxel-coated balloon catheter vs. uncoated balloon catheter in the SFA and PA to prevent restenosis or reocclusion-12-month data
| Speaker: | Ulf Teichgraeber, Jena, Germany |
Time: 14:22 - 14:28
ILLUMENATE European RCT two-year results
| Speaker: | Marianne Brodmann, Graz, Austria |
Time: 14:40 - 14:46
Sirolimus-eluting DCB for femoropopliteal lesions-the SELUTION trial
| Speaker: | Thomas Zeller, Bad Krozingen, Germany |
Time: 14:46 - 14:52
The ENDURE study outcomes and an update on the constrained expansion using nitinol struts randomised controlled trial
| Speaker: | Gunnar Tepe, Bad Rosenheim, Germany |
Time: 14:52 - 14:58
REAL PTX-DCB and BMS vs. Zilver PTX
| Speaker: | Arne Schwindt, Munster, Germany |
Stents, drug-eluting stents and bioabsorbable scaffolds
Time: 15:10 - 15:16
Sirolimus bioresorbable scaffold-an update on the DESappear trial
| Speaker: | Andrew Holden, Auckland, New Zealand |
Time: 15:16 - 15:22
The value of swirling flow-the BioMimics clinical study programme
| Speaker: | Peter Gaines, Sheffield, United Kingdom |
Tea
Time: 15:30 - 16:00
Stents, drug-eluting stents and bioabsorbable scaffolds (Cont'd)
| Chairing: | Andrew Holden, Auckland, New Zealand |
| Moderator: | Robert Morgan, President CIRSE, London,, United Kingdom |
Time: 16:00 - 16:06
The Evolution trial-safety and 12-month data on a self-expanding stent
| Speaker: | Marc Bosiers, Dendermonde, Belgium |
Time: 16:06 - 16:12
The use of nitonol interwoven stents in anatomies outside the SFA
| Speaker: | Rajiv Parakh, Gurgaon, India |
Access techniques and peri-interventional imaging
Time: 16:20 - 16:26
Retrograde tibial access for failed antegrade superficial femoral artery recanalisation
| Speaker: | Fabrizio Fanelli, Florence, Italy |
Time: 16:26 - 16:32
Retrograde femoral access for failed antegrade superficial femoral artery recanalisation
| Speaker: | Andrej Schmidt, Leipzig, Germany |
Time: 16:32 - 16:38
The potential value of IVUS guided superficial femoral artery interventions-a randomised trial
| Speaker: | Ian Spark, Kingswood, Australia |
Time: 16:38 - 16:44
Vector velocity ultrasound-a new ultrasound technique
| Speaker: | Lars Lönn, Copenhagen, Denmark |
Guidelines, recommendations and opinions
Time: 16:54 - 17:00
European Society of Cardiology and European Society for Vascular Surgery guidelines-ESC perspective
| Speaker: | Fabrizio Fanelli, Florence, Italy |
Time: 17:00 - 17:06
European Society of Cardiology and European Society for Vascular Surgery guidelines-ESVS perspective
| Speaker: | Jean-Baptiste Ricco, Poitiers, France |
Time: 17:16 - 17:28
CX Debate: Surgery is the only durable treatment option for in stent occlusion
For the motion
Time: 17:16 - 17:22
| Clement Darling III, SVS, President, Albany,, United States | |
| CLICK HERE TO VIEW VIDEO |
Against the motion
Time: 17:22 - 17:28
| Thomas Zeller, Bad Krozingen, Germany | |
| CLICK HERE TO VIEW VIDEO |
Time: 17:38 - 17:44
Limb salvage in acute ischaemia due to occlusion of popliteal aneurysm
| Speaker: | Thomas Wyss, Bern, Switzerland |
Time: 17:44 - 17:50
The cost of emergency peripheral events for the patient and the health service
| Speaker: | Dominic Howard, Oxford, United Kingdom |